SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.

MLA

Schmidt, Bernd, et al. “SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates.” BMC Cancer, vol. 10, Nov. 2010, p. 600. EBSCOhost, https://doi.org/10.1186/1471-2407-10-600.

APA

Schmidt, B., Liebenberg, V., Dietrich, D., Schlegel, T., Kneip, C., Seegebarth, A., Flemming, N., Seemann, S., Distler, J., Lewin, J., Tetzner, R., Weickmann, S., Wille, U., Liloglou, T., Raji, O., Walshaw, M., Fleischhacker, M., Witt, C., & Field, J. K. (2010). SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer, 10, 600. https://doi.org/10.1186/1471-2407-10-600

Chicago

Schmidt, Bernd, Volker Liebenberg, Dimo Dietrich, Thomas Schlegel, Christoph Kneip, Anke Seegebarth, Nadja Flemming, et al. 2010. “SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates.” BMC Cancer 10 (November): 600. doi:10.1186/1471-2407-10-600.